Iguratimod Impurity 2 | CAS 1179354-65-4 - Request Quote
Iguratimod Impurity 2
| SZ CAT No: | SZ-I062003 |
| CAS No | 1179354-65-4 |
| Mol.F. | C18H16N2O6S |
| Mol.Wt. | 388.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Iguratimod Impurity 2 is chemically N-(7-(N-Methylmethylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide. Iguratimod Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Iguratimod Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Iguratimod.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1179354-65-4
Purchase 1179354-65-4
Order 1179354-65-4
Enquire 1179354-65-4
price of 1179354-65-4
1179354-65-4 Supplier
1179354-65-4 Manufacturer
1179354-65-4 Exporter
buy high quality Iguratimod Impurity 2
Purchase Iguratimod Impurity 2
Iguratimod Impurity 2 suppliers
Iguratimod Impurity 2 manufacturers
Iguratimod Impurity 2 price
Order Iguratimod Impurity 2
Enquire Iguratimod Impurity 2
Iguratimod Impurity 2 cost
Iguratimod Impurity 2 Supplier
Iguratimod Impurity 2 Distributor
Iguratimod Impurity 2 for Method Validation
Iguratimod Reference Standard
Iguratimod Impurity 2 for ANDA Filing
Iguratimod Impurity 2 for Forced Degradation Studies
Iguratimod Impurity 2 Identification Standards
Iguratimod Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.